Drugmakers see long road ahead in coronavirus vaccine race
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/27/2026
- Wall Street stocks end tad lower after hot inflation data ahead of Nvidia earnings
- Nvidia forecasts quarterly revenue above estimates, shares rise
- Oil settles down after choppy session as investors weigh Hormuz talks
- Meta to pay up to $16.68 billion in mass social media settlement
- Anthropic agrees to $45bn cloud computing deal with Nscale - report
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- FDA approves Revolution Medicines pancreatic cancer drug Rasonque
- NVIDIA (NVDA) Tops Q2 EPS by 14c, Offers Guidance
Moderna (MRNA) Strength Tied to Comments from NIH on Vaccine
February 7, 2020 2:42 PM ESTStrength in Moderna (NASDAQ: MRNA) Friday was tied to comments from the NIH after it said there were "no glitches" in the early stages of a coronavirus vaccine. Comments were made during the Presidents Coronavirus Task Force briefing.
Shares gained 12%.
Johnson & Johnson (JNJ) Reports $750M in Punitive Damages Verdict for Failing to Warn about Cancer-Causing Asbestos in Talc Products
February 7, 2020 12:37 PM ESTA New Jersey jury has ordered Johnson & Johnson (NYSE: JNJ) to pay $750 million in punitive damages to four cancer victims who charged that the company's iconic Johnson's Baby Powder contained cancer-causing asbestos.
In assessing the punitive damages on Thursday, the jury agreed that J&J had acted "maliciously or in wanton disregard" of the safety risks of the four plaintiffs. In addition to the size of the damages, the verdict is significant because it occurred just blocks away from J&J's headquarters, said trial lawyer... More
